Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Megakaryocyte development and platelet production.

Varda R Deutsch1, Aaron Tomer

  • 1The Haematology Institute, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel. varda@tasmc.health.gov.il

British Journal of Haematology
|July 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenic heparin-induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry.

European journal of haematology·2019
Same author

DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score.

PloS one·2014
Same author

Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.

British journal of haematology·2013
Same author

[Megakaryocyte development and platelet production in normal and disease states].

Harefuah·2010
Same author

Engraftment of human blood malignancies to the turkey embryo: a robust new in vivo model.

Leukemia research·2009
Same author

Platelet counts and platelet activation markers in obese subjects.

Mediators of inflammation·2008

This review details megakaryocytopoiesis and platelet production, focusing on thrombopoietin (TPO) signaling via the c-Mpl receptor. It explores therapeutic strategies for thrombocytopenia.

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Megakaryocytopoiesis is the process of megakaryocyte (MK) development from hematopoietic stem cells.
  • Thrombopoietin (TPO) is the primary growth factor regulating MK proliferation and maturation through the c-Mpl receptor.
  • Platelet production is a complex process involving MK differentiation and proplatelet formation.

Purpose of the Study:

  • To review the regulation of megakaryocytopoiesis and platelet production in normal and disease states.
  • To discuss the role of thrombopoietin (TPO) and its receptor c-Mpl in regulating platelet production.
  • To explore novel thrombopoietic therapies for thrombocytopenic conditions.

Main Methods:

  • Review of existing literature on megakaryocytopoiesis and thrombopoiesis.

Related Experiment Videos

  • Analysis of signaling pathways involved in megakaryocyte maturation and platelet formation.
  • Examination of current and emerging thrombopoietic agents.

    • Main Results:

    • TPO concentration directly influences MK progenitor proliferation and maturation via c-Mpl.
    • A complex signaling cascade involving transcription factors drives MK development.
    • Mature MKs generate proplatelets that fragment into circulating platelets.
    • Dysregulation of these processes contributes to various disease states.

    Conclusions:

    • Understanding TPO-c-Mpl signaling is crucial for regulating platelet production.
    • New thrombopoietic agents targeting the c-Mpl pathway offer potential therapeutic benefits.
    • Further research into megakaryocytopoiesis regulation can lead to improved treatments for thrombocytopenia.